Vivien Hsu is a Rheumatology/Immunology physician affiliated with Rutgers. OpenAlex indexes 96 publications with 15,190 citations (h-index 39). By OpenAlex citation count, this profile ranks in the top 10% of Rheumatology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GSKProgram year202510 paymentsResearch$22,863
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20255 payments$7,196
- NovartisProgram year20251 paymentResearch$733
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
29.3%Folate Analog Metabolic Inhibitor16.9%Methotrexate95%Methotrexate Sodium5%Part D<11 patientsKinase inhibitor7.6%Ofev100%Part D≥15 patients+ 3 more classes in this area
Metabolism & gastrointestinal
23.8%Proton pump inhibitor13.9%Omeprazole70%Pantoprazole Sodium30%Part D≥34 patientsCorticosteroid7.8%Prednisone100%Part D≥42 patients+ 1 more class in this area
Cardiovascular
19%Endothelin Receptor Antagonist9.1%Ambrisentan78%Letairis13%Opsumit9%Part D<11 patientsCalcium channel blocker5.8%Amlodipine Besylate63%Nifedipine Er37%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Reynold Panettieri, MD
Rutgers
Manreet Kanwar, MD
Rutgers
Brenda Kurnik, MD
Rutgers
Jacob Sage, MD
Rutgers
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”